phd pharmacy cardiff university

Personalise what you see on this page.

Looking for.

• Undergraduate courses
• Clearing courses
• Postgraduate courses

Change here for Clearing courses

• CHOOSE ONE OR MORE

Popular universities

• University of Kent
• University of East Anglia UEA
• University of Chester
• Coventry University
• University of Aberdeen
• University of Portmouth
• Nottingham Trent University
• University of Sunderland
• London Metropolitan University
• London South Bank University
• University of East London
• BROWSE ALL UNIVERSITIES

Course search

Popular undergraduate courses.

• Computer Science
• LLB Bachelor of Laws
• Biomedical Sciences
• Physiotherapy
• Sports Science

Open days search

Upcoming open days.

• Ulster University
• Lancaster University

Cardiff University

• Ravensbourne University London
• University of Roehampton
• University of Nottingham

Article search

Popular topics.

• Clearing advice for students
• Clearing advice for parents
• Clearing advice for teachers
• League tables
• Getting ready for uni

Popular articles

• What is UCAS Extra?
• Applying directly into Clearing
• Clearing success stories
• What's a university open day
• How university rankings can help you through Clearing
• BROWSE ALL ADVICE

You are looking at:

Courses starting in 2025

Looking for Clearing information?

Pharmacy and Pharmaceutical Sciences (MPhil, MD, PhD) Cardiff University

Course options

Qualification.

PhD/DPhil - Doctor of Philosophy

01-OCT-24, 02-JAN-25, 01-APR-25, 01-JUL-25

• TUITION FEES
• ENTRY REQUIREMENT
• UNIVERSITY INFO

Course summary

We welcome applications from students interested in researching for a PhD within our diverse research portfolio. We focus on the discovery, development and optimised use of medicines and therapeutics to tackle some of the world’s most debilitating and life-threatening diseases and improving patient health outcomes.

The excellence of our pharmaceutical sciences and health related research and teaching is recognised internationally. We rank joint first as a School of Pharmacy and Pharmaceutical Sciences in the UK for our research and teaching excellence according the most recent Research Excellence Framework (REF 2014).

Our research spans the continuum from basic to applied, translational science and clinical practice. It encompasses the discovery, development and usage of medicines and therapeutics across a spectrum of diseases including cancer, infection, musculoskeletal, cardiovascular, respiratory and neurodegenerative disorders.

Our research includes all aspects of the study of drugs, including:

• the discovery of new potential drug entities using synthetic chemistry
• formulation of drugs to achieve targeted responses
• pharmacological studies of mechanisms of drug action
• medicines management to pharmaceutical practice and education.

The applied and multidisciplinary nature of our work benefits from worldwide scientific collaborations and strategic relationships with global businesses and public sector bodies that enable us to see the real-world impact of our research.

You will be fully integrated into our research and academic community. You will be provided with the tools, support, and opportunity to contribute to the advancement of knowledge and generate impact in your chosen research discipline.

You will study and work in a self-contained multi-disciplinary School, with opportunities for collaboration with related departments in our College of Biomedical and Life Sciences, or with the University’s Schools of Chemistry or Engineering.

We welcome applications from students interested in researching for a PhD in a specialist area within our diverse research portfolio.

Tuition fees

• Afghanistan
• Antigua & Barbuda
• Bosnia and Herzegovina
• Burkina Faso
• Central African Republic
• Congo (Democratic Republic)
• Czech Republic
• Dominican Republic
• El Salvador
• Equatorial Guinea
• Guinea-Bissau
• Ivory Coast
• Korea DPR (North Korea)
• Liechtenstein
• Marshall Islands
• Netherlands
• New Zealand
• Northern Ireland
• Palestinian Authority
• Papua New Guinea
• Philippines
• Puerto Rico
• Republic of Ireland
• Sao Tome and Principe
• Saudi Arabia
• Sierra Leone
• Solomon Islands
• South Africa
• South Korea
• South Sudan
• St. Kitts & Nevis
• Switzerland
• Trinidad & Tobago
• Turkmenistan
• United Kingdom
• United States
• Vatican City
• Western Samoa

Information not available

Please check with the institution for most up to date details.

University information

University League Table

Campus address.

Cardiff University, PO Box 921, Cardiff, Cardiff, CF10 3XQ, Wales

Subject rankings

Subject ranking.

5th out of 45 1

Entry standards

Graduate prospects

Student satisfaction

Is this page useful?

Sorry about that..., how can we improve it, thanks for your feedback.

• Search PhD Projects & Programmes
• PhDs by Subject
• PhDs by Institution
• Latest PhDs

Cardiff University

Cardiff University is recognised in independent government assessments as one of Britain's leading teaching and research universities. The University's breadth of expertise in research and research-led teaching encompasses: the humanities; the natural, physical, health, life and social sciences; engineering and technology; preparation for a wide range of professions; and a longstanding commitment to lifelong learning. The University is also home to three major new Research Institutes, offering radical new approaches to neurosciences and mental health, cancer stem cells and sustainable places.

By Department/School/Faculty

FindAPhD. Copyright 2005-2024 All rights reserved.

Unknown    ( change )

Have you got time to answer some quick questions about PhD study?

Select your nearest city

You haven’t completed your profile yet. To get the most out of FindAPhD, finish your profile and receive these benefits:

• Monthly chance to win one of ten £10 Amazon vouchers ; winners will be notified every month.*
• The latest PhD projects delivered straight to your inbox
• Access to our £6,000 scholarship competition
• Weekly newsletter with funding opportunities, research proposal tips and much more
• Early access to our physical and virtual postgraduate study fairs

Or begin browsing FindAPhD.com

or begin browsing FindAPhD.com

*Offer only available for the duration of your active subscription, and subject to change. You MUST claim your prize within 72 hours, if not we will redraw.

Create your account

Looking to list your PhD opportunities? Log in here .

Give to the School

Alexander V. Kabanov , PhD

Adjunct Professor Director Mescal Swain Ferguson Distinguished Prof

Alexander V. Kabanov, Ph.D., Dr.Sci.

Director, center for nanotechnology in drug delivery, mescal swain ferguson distinguished professor, center for nanotechnology in drug delivery, adjunct professor, unc department of biomedical engineering, current projects, honors and awards.

Alexander “Sasha” Kabanov, Ph.D., D.Sc., is the Mescal S. Ferguson Distinguished Professor and director of the  Center for Nanotechnology in Drug Delivery  at the UNC Eshelman School of Pharmacy and co-director of the  Carolina Institute for Nanomedicine  at the University of North Carolina at Chapel Hill.

Kabanov began his academic journey at M. V. Lomonosov Moscow State University (MSU), where he graduated in 1984. He continued his studies at the same institution, earning a Ph.D. in 1987 and a D.Sc. in 1990. His scientific career took root in the Soviet Union and later transitioned to the United States. From 1994 to 2012, Kabanov was affiliated with the University of Nebraska Medical Center in Omaha, Nebraska. During his tenure there, he established the first academic nanomedicine center in the United States in 2004.

In 2012, Kabanov moved to the University of North Carolina at Chapel Hill where his research focuses on several key areas.

• Polymeric Micelles : Kabanov co-developed the first polymeric micelle drug that entered clinical trials for cancer treatment, thereby establishing polymeric micelles as a clinically approved drug delivery platform.
• Polyplexes : Kabanov was among the first to use polycations and later, cationic block copolymers for delivering nucleic acids into cells. He evaluated core-shell polyelectrolyte complexes of nucleic acids and polypeptides, now known as “polyplexes”, for therapeutic drug and gene delivery.
• Nanogels, Nanoparticle-Macrophage Carriers, and Exosomes : These have been utilized for delivering small drugs, nucleic acids, and polypeptides to treat cancers and diseases of the central nervous system.

Kabanov is a highly cited researcher, with over 340 scientific papers (garnering over 50,000 citations, and a Google h-index greater than 115), 36 US patents, and has co-founded several pharmaceutical companies. His cumulative research support in academia has been over $120 million.

Kabanov has mentored more than 80 graduate students and postdocs, half of whom are women and underrepresented minorities. Nineteen past members of Kabanov laboratory hold faculty appointments. He is the director of the NCI’s T32 training program in Cancer Nanotechnology .

Kabanov also established symposium series in nanomedicine and drug delivery , chaired Gordon Research Conferences, and received numerous honors and awards, including the Lenin Komsomol Prize, NSF Career award, George Gamow award, and the Controlled Release Society (CRS) Founders award.

Kabanov is an elected member or fellow of prestigious academies and organizations, including Academia Europaea, Russian Academy of Sciences, National Academy of Inventors, American Association for the Advancement of Science, American Institute for Medical and Biological Engineering, and CRS. He has served as the past President and current CEO of the Russian American Science Association, director-at-large for CRS (2019-2022), and chair of the CRS College of Fellows sub-committee (2022-2023).

Education, Certification and Licensure

• 1990: Doctor of Chemical Sciences (D.Sc.) in Chemical Kinetics and Catalysis and Biochemistry at Moscow State University
• 1984 – 1987: Candidate of Chemical Sciences (Ph.D. equivalent) in Chemical Kinetics and Catalysis at Moscow State University
• 1979 – 1984: Diploma with distinction (M.S. equivalent) in Chemistry at Moscow State University

Courses and Lectures

DPMP 862/863 “Special Topics in Advanced Pharmaceutics” 3 cr.

Office Hours

By appointment only

Google Scholar

Lab Website

Twitter @alkabanov

ORCID iD: 0000-0002-3665-946X

• Carolina Cancer Nanotechnology Training Program (C-CNTP)
• Towards Translation of Nanoformulated Paclitaxel-Platinum Combination
• Extracellular Vesicles for CNS Delivery of Therapeutic Enzymes to Treat Lysosomal Storage Disorders
• Cell-based Platform for Gene Delivery to the Brain

Highly Cited Researcher: Thompson Reuters/Clarivate Analytics – Pharmacology & Toxicology (2014, 2018, 2021)

Huang, Kabanov and Roth Recognized for Research Influence

Three faculty members from the UNC Eshelman School of Pharmacy were recognized on the Clarivate Analytics list of Highly Cited Researchers for 2018. Leaf Huang, Ph.D., Alexander Kabanov, Ph.D., Dr.Sci., and Bryan Roth, Ph.D., M.D., were among 6,000 scientists worldwide … Read more

Kabanov Named President of Russian-American Scientists Association

Alexander Kabanov, Ph.D., Dr.Sci., assumed office as president of the Russian-American Scientists Association (RASA-America) on Nov. 5. Kabanov is the Mescal S. Ferguson Distinguished Professor and director of the Center for Nanotechnology in Drug Delivery at the UNC Eshelman School of Pharmacy and … Read more

Kabanov Elected 2018 Controlled Release Society Fellow

Alexander “Sasha” Kabanov, Ph.D., Dr. Sci., has been selected for membership in the College of Fellows of the Controlled Release Society for his “outstanding contributions to the field of delivery science and technology.” Kabanov will be inducted into the college … Read more

Kabanov Receives TBJ Life Sciences Award

Alexander “Sasha” Kabanov, Ph.D., Dr. Sci., is a recipient of a 2018 Life Sciences Award from the Triangle Business Journal. Kabanov was nominated in the category of Outstanding Individual Research from Universities or Research Institutes. The award was presented at … Read more

Third Carolina Nanoformulation Workshop Shares Discoveries in Nanomedicine

From March 12 to 16, scientists from industry and academia came together at the UNC Eshelman School of Pharmacy to learn about the latest advances in nanomedicine and to get hands-on experience with advanced nanoformulations at the third annual Carolina … Read more

Kabanov to Lead Russian-American Science Society

Alexander “Sasha” Kabanov, Ph.D., Dr.Sci., is the president-elect of the Russian-American Science Association. Kabanov was elected to his new post at the organization’s annual meeting at Northwestern University in Chicago on Nov. 4 and 5, where he also received the … Read more

Kabanov Elected to National Academy of Inventors

Alexander “Sasha” Kabanov, Ph.D., Dr.Sci., Mescal Swaim Feruguson Distinguished Professor at the UNC Eshelman School of Pharmacy, has been named a Fellow of the National Academy of Inventors, the organization announced Tuesday. Kabanov is the director of the School’s Center … Read more

Kabanov Meets with President of Armenia

Alexander “Sasha” Kabanov, Ph.D., met with the president of Armenia on Nov. 8 as part of a group of participants in the second All-Armenian Scientific Conference held in the capital city of Yerevan on November 5-8. The delegation consisted of … Read more

Postdoc Elizabeth Wayne Reflects on TED Experience

Elizabeth Wayne, Ph.D., a postdoctoral fellow studying how immune cells can be used to fight cancer, gave a TED talk on the main stage at TED 2017 in Vancouver, Canada. Wayne was announced as a TED fellow in January 2017. … Read more

Yuhang Jiang Wins UNC Grad School Impact Award

Yuhang Jiang, Ph.D., a December 2016 graduate of the pharmaceutical sciences doctoral program at the UNC Eshelman School of Pharmacy, has received a 2017 Horizon Award from the UNC Graduate School for his research into a treatment to repair the … Read more

Dr Youcef Mehellou

School of Pharmacy and Pharmaceutical Sciences

• Publications

I joined Cardiff School of Pharmacy and Pharmaceutical Sciences in January 2017 where I am now a Senior Lecturer in Medicinal Chemistry. Prior to this, I held a Lectureship position at the University of Birmingham.

After receiving my MPharm degree from King’s College London in 2005, I joined the lab of Prof. Chris McGuigan at Cardiff University for a PhD in Medicinal Chemistry. In early 2009, I moved to Arizona State University (USA) to work as a postdoctoral scientist with Prof. Sidney M. Hecht on the synthesis of unnatural amino acids. In mid-2010, I was awarded an MRC Career Development Fellowship that was held in the lab of Prof. Dario R. Alessi FRS, University of Dundee, until March 2013 when I joined the University of Birmingham.

Current active projects in the lab are:

• Parkinson’s Disease: PINK1/Parkin signalling.
• Cancer and Infections: T-cell immunotherapy.
• Mitochondrial Diseases: nucleoside and nucleotide therapy.
• Cancer and Autoimmune Diseases: SH2 domain inhibitors.
• Hypertension: WNK-SPAK/OSR1 signalling.

Further details on these projects could be found on  www.mehelloulab.com/research

Qualifications

• MPharm (Pharmacy), King’s College London, 2005.
• PhD in Medicinal Chemistry. Cardiff University, 2009.

Publication

• Xu, Q., Sharif, M., James, E., Dismorr, J. O., Tucker, J. H. R., Willcox, B. E. and Mehellou, Y. 2024. Phosphonodiamidate prodrugs of phosphoantigens (ProPAgens) exhibit potent Vγ9/Vδ2 T cell activation and eradication of cancer cells † . RSC Medicinal Chemistry 15(7), pp. 2462-2473. ( 10.1039/d4md00208c )
• Mehellou, Y. 2023. Parkinson's disease: are PINK1 activators inching closer to the clinic? . ACS Medicinal Chemistry Letters 14(7), pp. 870-874. ( 10.1021/acsmedchemlett.3c00070 )
• Lambourne, O. A. et al. 2023. PINK1-Dependent mitophagy inhibits elevated ubiquitin phosphorylation caused by mitochondrial damage . Journal of Medicinal Chemistry 66(11), pp. 7645-7656. ( 10.1021/acs.jmedchem.3c00555 )
• Elvers, K. T., Lipka-Lloyd, M., Trueman, R. C., Bax, B. D. and Mehellou, Y. 2022. Structures of the human SPAK and OSR1 conserved C-terminal (CCT) domains . ChemBioChem 23(1), article number: e202100441. ( 10.1002/cbic.202100441 )
• Alanazi, A. S., Miccoli, A. and Mehellou, Y. 2021. Aryloxy pivaloyloxymethyl prodrugs as nucleoside monophosphate prodrugs . Journal of Medicinal Chemistry 64(22), pp. 16703–16710. ( 10.1021/acs.jmedchem.1c01490 )
• Xu, Q., Taher, T. E., Ashby, E., Sharif, M., Willcox, B. E. and Mehellou, Y. 2021. Generation of stable isopentenyl monophosphate aryloxy triester phosphoramidates as activators of Vγ9Vδ2 T cells . ChemMedChem 16(15), pp. 2375-2380. ( 10.1002/cmdc.202100198 )
• Elzwawi, A., Grafton, G., Barnes, N. M. and Mehellou, Y. 2020. SPAK and OSR1 kinases bind and phosphorylate the β2-Adrenergic receptor . Biochemical and Biophysical Research Communications 532(1), pp. 88-93. ( 10.1016/j.bbrc.2020.07.143 )
• Kadri, H. et al. 2020. Aryloxy diester phosphonamidate prodrugs of phosphoantigens (ProPAgens) as potent activators of Vγ9/Vδ2 T-Cell immune responses . Journal of Medicinal Chemistry 63(19), pp. 11258-11270. ( 10.1021/acs.jmedchem.0c01232 )
• Miccoli, A., Dhiani, B. A., Thornton, P. J., Lambourne, O. A., James, E., Kadri, H. and Mehellou, Y. 2020. Aryloxy triester phosphoramidates as phosphoserine prodrugs: a proof of concept study . ChemMedChem 15(8), pp. 671-674. ( 10.1002/cmdc.202000034 )
• Dhiani, B. A. and Mehellou, Y. 2020. The Cul4‐DDB1‐WDR3/WDR6 complex binds SPAK and OSR1 kinases in a phosphorylation‐dependent manner . ChemBioChem 21(5), pp. 638-643. ( 10.1002/cbic.201900454 )
• AlAmri, M. A., Jeeves, M. and Mehellou, Y. 2019. Sequence specific assignment and determination of OSR1 C-terminal domain structure by NMR . Biochemical and Biophysical Research Communications 512(2), pp. 338-343. ( 10.1016/j.bbrc.2019.03.065 )
• Miccoli, A., Dhiani, B. and Mehellou, Y. 2019. Phosphotyrosine prodrugs: design, synthesis and anti-STAT3 activity of ISS-610 aryloxy triester phosphoramidate prodrugs . MedChemComm 10(2), pp. 200-208. ( 10.1039/C8MD00244D )
• Alanazi, A. S., James, E. and Mehellou, Y. 2019. The protide prodrug technology: Where next? . ACS Medicinal Chemistry Letters 10(1), pp. 2-5. ( 10.1021/acsmedchemlett.8b00586 )
• Lambourne, O. A. and Mehellou, Y. 2018. Chemical strategies for activating PINK1, a protein kinase mutated in Parkinson's Disease . ChemBioChem 19(23), pp. 2433-2437. ( 10.1002/cbic.201800497 )
• AlAmri, M. A., Kadri, H., Jeeves, M., Alderwick, L. J. and Mehellou, Y. 2018. The photosensitizing clinical agent verteporfin is an inhibitor of SPAK and OSR1 kinases . ChemBioChem 19(19), pp. 2072-2080. ( 10.1002/cbic.201800272 )
• Mehellou, Y., Alamri, M. A., Dhiani, B. A. and Kadri, H. 2018. C -terminal phosphorylation of SPAK and OSR1 kinases promotes their binding and activation by the scaffolding protein MO25 . Biochemical and Biophysical Research Communications 503(3), pp. 1868-1873. ( 10.1016/j.bbrc.2018.07.128 )
• Kadri, H., Lambourne, O. A. and Mehellou, Y. 2018. Niclosamide, a drug with many (re)purposes . ChemMedChem 13(11), pp. 1088-1091. ( 10.1002/cmdc.201800100 )
• Mehellou, Y., Rattan, H. S. and Balzarini, J. 2018. The ProTide prodrug technology: from the concept to the clinic . Journal of Medicinal Chemistry 61(6), pp. 2211-2226. ( 10.1021/acs.jmedchem.7b00734 )
• Davey, M. S. et al. 2018. Synthesis and biological evaluation of (E)-4-hydroxy-3-methylbut2-enyl phosphate (HMBP) aryloxy triester phosphoramidate Prdrugs as activators of Vγ9/Vδ2 T-cells immune response . Journal of Medicinal Chemistry 61(5), pp. 2111-2117. ( 10.1021/acs.jmedchem.7b01824 )
• Barini, E. et al. 2018. The anthelmintic drug niclosamide and its analogues activate the Parkinson's Disease associated protein kinase PINK1 . Chembiochem 19(5), pp. 425-429. ( 10.1002/cbic.201700500 )
• Salim, M. et al. 2017. BTN3A1 discriminates γδ T cell phosphoantigens from non-antigenic small molecules via a conformational sensor in its B30.2 domain . ACS Chemical Biology 12(10), pp. 2631-2643. ( 10.1021/acschembio.7b00694 )
• AlAmri, M. A., Kadri, H., Dhiani, B. A., Mahmood, S., Elzwawi, A. and Mehellou, Y. 2017. WNK-signaling inhibitors as potential new antihypertensive drugs . Chemmedchem ( 10.1002/cmdc.201700425 )
• Alamri, M. A., Kadri, H., Alderwick, L. J., Simpkins, N. S. and Mehellou, Y. 2017. Rafoxanide and Closantel inhibit SPAK and OSR1 kinases by binding to a highly conserved allosteric site on their C-terminal domains . ChemMedChem 12(9), pp. 639-645. ( 10.1002/cmdc.201700077 )
• Osgerby, L. et al. 2017. Kinetin riboside and its ProTides activate the Parkinson's Disease associated PTEN-Induced Putative Kinase 1 (PINK1) independent of mitochondrial depolarization . Journal of Medicinal Chemistry 60(8), pp. 3518-3524. ( 10.1021/acs.jmedchem.6b01897 )
• Kadri, H., Alamri, M. A., Navratilova, I. H., Alderwick, L. J., Simpkins, N. S. and Mehellou, Y. 2017. Towards the development of small molecule MO25-binders as potential indirect SPAK/OSR1 kinase inhibitors . ChemBioChem 18(5), pp. 460-465. ( 10.1002/cbic.201600620 )
• Kedge, J. L. et al. 2017. Organometallic nucleoside analogues: effect of hydroxyalkyl linker length on cancer cell line toxicity . European Journal of Inorganic Chemistry 2017(2), pp. 466-476. ( 10.1002/ejic.201600853 )
• Thornton, P. J., Kadri, H., Miccoli, A. and Mehellou, Y. 2016. Nucleoside phosphate and phosphonate prodrug clinical candidates . Journal of Medicinal Chemistry 59(23), pp. 10400-10410. ( 10.1021/acs.jmedchem.6b00523 )
• Mehellou, Y. 2016. The ProTides boom . Chemmedchem 11(11), pp. 1114-1116. ( 10.1002/cmdc.201600156 )
• Nguyen, H. V. et al. 2014. Organometallic nucleoside analogues with ferrocenyl linker groups: Synthesis and cancer cell line studies . Journal of Medicinal Chemistry 57(13), pp. 5817-5822. ( 10.1021/jm500246h )
• Ohta, A. et al. 2013. The CUL3–KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction . Biochemical Journal 451(1), pp. 111-122. ( 10.1042/BJ20121903 )
• Mehellou, Y., Alessi, D. R., Macartney, T. J., Szklarz, M., Knapp, S. and Elkins, J. M. 2013. Structural insights into the activation of MST3 by MO25 . Biochemical and Biophysical Research Communications 431(3), pp. 604-609. ( 10.1016/j.bbrc.2012.12.113 )
• Chen, S., Fahmi, N. E., Nangreave, R. C., Mehellou, Y. and Hecht, S. M. 2012. Synthesis of pdCpAs and transfer RNAs activated with thiothreonine and derivatives . Bioorganic & Medicinal Chemistry 20(8), pp. 2679-2689. ( 10.1016/j.bmc.2012.02.024 )
• Thastrup, J., Rafiqi, F., Vitari, A., Pozo-Guisado, E., Deak, M., Mehellou, Y. and Alessi, D. 2012. SPAK/OSR1 regulate NKCC1 and WNK activity: analysis of WNK isoform interactions and activation by T-loop trans-autophosphorylation . Biochemical Journal 441(1), pp. 325-337. ( 10.1042/BJ20111879 )
• Filippi, B. M. et al. 2011. MO25 is a master regulator of SPAK/OSR1 and MST3/MST4/YSK1 protein kinases . EMBO Journal 30(9), pp. 1730-1741. ( 10.1038/emboj.2011.78 )
• Mehellou, Y. 2010. Phosphoramidate Prodrugs Deliver with Potency Against Hepatitis C Virus . ChemMedChem 5(11), pp. 1841-1842. ( 10.1002/cmdc.201000310 )
• Mehellou, Y., Valente, R., Mottram, H. J., Walsby, E. J., Mills, K. I., Balzarini, J. and McGuigan, C. 2010. Phosphoramidates of 2′-β-d-arabinouridine (AraU) as phosphate prodrugs; design, synthesis, in vitro activity and metabolism . Bioorganic & Medicinal Chemistry 18(7), pp. 2439-2446. ( 10.1016/j.bmc.2010.02.059 )
• Mehellou, Y., Balzarini, J. and McGuigan, C. 2010. The design, synthesis and antiviral evaluation of a series of 5-trimethylsilyl-1-β-D-(arabinofuranosyl)uracil phosphoramidate ProTides . Antiviral Chemistry & Chemotherapy 20(4), pp. 153-160. ( 10.3851/IMP1476 )
• Mehellou, Y. and De Clercq, E. 2010. Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go? . Journal of Medicinal Chemistry 53(2), pp. 521-538. ( 10.1021/jm900492g )
• Mehellou, Y., Balzarini, J. and McGuigan, C. 2009. An investigation into the anti-HIV activity of 2 ',3 '-didehydro-2 ',3 '-dideoxyuridine (d4U) and 2 ',3 '-dideoxyuridine (ddU) phosphoramidate 'ProTide' derivatives . Organic and Biomolecular Chemistry 7(12), pp. 2548-2553. ( 10.1039/b904276h )
• Mehellou, Y., Balzarini, J. and McGuigan, C. 2009. Aryloxy Phosphoramidate Triesters: a Technology for Delivering Monophosphorylated Nucleosides and Sugars into Cells . Chemmedchem 4(11), pp. 1779-1791. ( 10.1002/cmdc.200900289 )
• Mehellou, Y., McGuigan, C., Brancale, A. and Balzarini, J. 2007. Design, synthesis, and anti-HIV activity of 2',3'-didehydro-2',3'-dideoxyuridine (d4U), 2',3'-dideoxyuridine (ddU) phosphoramidate "ProTide' derivatives . Biorganic and Medicinal Chemistry Letters 17(13), pp. 3666-3669. ( 10.1016/j.bmcl.2007.04.043 )
• Mehellou, Y., McGuigan, C. and Balzarini, J. 2007. The design, synthesis and Anti-HIV activity of a selected group of 2 ',3 '-didehydro-2 ',3 '-dideoxyguanosine (d4G) and 2 ',3 '-dideoxyguanosine (ddG) 'ProTide' derivatives . Antiviral Research 74(3), article number: 50. ( 10.1016/j.antiviral.2007.01.063 )

My lab works on unravelling the roles of phosphates in cell signalling and drug discovery. To this end, we dive into cells to understand how protein kinases operate within complex signalling pathways. Such endeavour allows us to identify opportunities for discovering new medicines for diseases with unmet medical needs.

Our research is highly interdisciplinary and involves techniques and skills that span Biochemistry, Protein Crystallography, Synthetic and Medicinal Chemistry.

Detailed summary of the lab's research projects could be found here .

Further details about the lab's activities could be found at www.mehelloulab.com .

Lay Research Summary

Our research focuses on understanding the function of proteins that are important in the development and progression of many diseases such as Parkinson’s disease, hypertension and cancer. We utilise the improved understanding of these diseases to discover new drugs that treat them. To successfully achieve our research goals, we employ techniques and skills from different scientific fields including chemistry, biology and medicine. Through this research discovery process, we aim to inspire students and offer them outstanding training opportunities to become successful scientists and researchers.

Collectively, our research and training opportunities will have far reaching impact that covers science, education, health, the economy, quality of life and general well-being.

I obtained my Ph.D. from the Welsh School of Pharmacy, Cardiff University. My postgraduate research was carried out in the laboratory of Prof. Christopher McGuigan. The project was on the design, synthesis and development of nucleoside analogues and their phosphate prodrugs (Phosphoramidates) as potential antiviral and anticancer therapies. During this work, I synthesised a large number of nucleoside analogues and their phosphoramidate derivatives and explored their potential as antiviral and anticancer compounds in collaboration with Prof. Jan Balzarini. I used molecular modelling as well as NMR studies to investigate the differences in biological activities seen with some of the nucleoside analogues phosphoramidates.

This was followed by a Postdoc with Prof. Sidney M. Hecht at the Biodesign Institute, Arizona State University, USA. My work then was on the development of chemical strategies that allow the incorporation of unnatural amino acids into proteins. This involved the synthesis of unnatural amino acids and ligating them to synthetic dinucleotides.

In late 2010, I took a position as an MRC Career Development Fellow with Prof. Dario R. Alessi FRS at the MRC Protein Phosphorylation and Ubiquitylation Unit (MRC PPU), University of Dundee. While in this position, My work was concerned with the regulation of the catalytic activity of kinases, particularly SPAK, OSR1 and MSTs, by the scaffolding protein MO25. I solved the crystal structure of the kinase MST3 in complex with MO25, which shed some light on the activation of kinases by MO25. I also worked on developing high throughput screening assays for identifying small molecules that inhibit various components of the WNK signalling pathway of which SPAK and OSR1 kinases are part of.

Honours and awards

• MRC Career Development Fellowship (2010-2013).

Professional memberships

• Member of the Biochemical Society.
• Member of the Royal Society of Chemistry.
• Member of the Biochemical Society Signalling theme Panel.

Related news

New 3D shapes of two proteins involved in stroke and cancer have been determined

15 November 2021

School of Pharmacy researchers develop new compound to fight cancer

22 September 2020

The resurrection of phospho-amino acid containing drugs

06 December 2019

External profiles

• Personal website

This profile is not university owned. Do you still want to proceed?

59 Best universities for Pharmacy in Russia

Updated: February 29, 2024

• Art & Design
• Computer Science
• Engineering
• Environmental Science
• Liberal Arts & Social Sciences
• Mathematics

Below is a list of best universities in Russia ranked based on their research performance in Pharmacy. A graph of 175K citations received by 25.5K academic papers made by 59 universities in Russia was used to calculate publications' ratings, which then were adjusted for release dates and added to final scores.

We don't distinguish between undergraduate and graduate programs nor do we adjust for current majors offered. You can find information about granted degrees on a university page but always double-check with the university website.

1. Moscow State University

For Pharmacy

2. St. Petersburg State University

3. Southern Federal University

4. Ural Federal University

5. Kazan Federal University

6. RUDN University

7. Saint Petersburg State Institute of Technology

8. Perm State University

9. Novosibirsk State University

10. Chuvash State University

11. mendeleev university of chemical technology of russia.

12. Samara State Technical University

13. Saratov State University

14. Kazan State Technological University

15. Voronezh State University

16. Ivanovo State University of Chemistry and Technology

17. Ivanovo State University

18. Kuban State University of Technology

19. Omsk State University

20. Irkutsk State University

21. South Ural State University

22. Moscow State Pedagogical University

23. North Caucasus Federal University

24. N.R.U. Moscow Power Engineering Institute

25. Lobachevsky State University of Nizhni Novgorod

26. Tomsk State University

27. Novgorod State University

28. tomsk polytechnic university.

29. Kuban State University

30. Ufa State Petroleum Technological University

31. Astrakhan State University

32. Volgograd State Medical Academy

33. Moscow Medical Academy

34. Bashkir State University

35. Russian State Agricultural University

36. Ogarev Mordovia State University

37. Far Eastern Federal University

38. Yaroslavl State University

39. Leningrad State University

40. Nizhny Novgorod State Technical University

41. Ryazan State University

42. Samara National Research University

43. Russian National Research Medical University

44. Plekhanov Russian University of Economics

45. University of Tyumen

46. Russian State University of Oil and Gas

47. siberian state medical university.

48. Kazan State Medical University

49. Petrozavodsk State University

50. ITMO University

51. Astrakhan State Technical University

52. Moscow Institute of Physics and Technology

53. Immanuel Kant Baltic Federal University

54. Omsk State Technical University

55. Siberian Federal University

56. National University of Science and Technology "MISIS"

57. National Research University Higher School of Economics

58. Bauman Moscow State Technical University

59. Chechen State University

The best cities to study Pharmacy in Russia based on the number of universities and their ranks are Moscow , Saint Petersburg , Rostov-on-Don , and Yekaterinburg .

Medicine subfields in Russia

Our cookies

We use cookies for three reasons: to give you the best experience on PGS, to make sure the PGS ads you see on other sites are relevant , and to measure website usage. Some of these cookies are necessary to help the site work properly and can’t be switched off. Cookies also support us to provide our services for free, and by click on “Accept” below, you are agreeing to our use of cookies .You can manage your preferences now or at any time.

Privacy overview

We use cookies, which are small text files placed on your computer, to allow the site to work for you, improve your user experience, to provide us with information about how our site is used, and to deliver personalised ads which help fund our work and deliver our service to you for free.

The information does not usually directly identify you, but it can give you a more personalised web experience.

You can accept all, or else manage cookies individually. However, blocking some types of cookies may affect your experience of the site and the services we are able to offer.

You can change your cookies preference at any time by visiting our Cookies Notice page. Please remember to clear your browsing data and cookies when you change your cookies preferences. This will remove all cookies previously placed on your browser.

For more detailed information about the cookies we use, or how to clear your browser cookies data see our Cookies Notice

Manage consent preferences

Strictly necessary cookies

These cookies are necessary for the website to function and cannot be switched off in our systems.

They are essential for you to browse the website and use its features.

You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. We can’t identify you from these cookies.

Functional cookies

These help us personalise our sites for you by remembering your preferences and settings. They may be set by us or by third party providers, whose services we have added to our pages. If you do not allow these cookies, then these services may not function properly.

Performance cookies

These cookies allow us to count visits and see where our traffic comes from, so we can measure and improve the performance of our site. They help us to know which pages are popular and see how visitors move around the site. The cookies cannot directly identify any individual users.

If you do not allow these cookies we will not know when you have visited our site and will not be able to improve its performance for you.

Marketing cookies

These cookies may be set through our site by social media services or our advertising partners. Social media cookies enable you to share our content with your friends and networks. They can track your browser across other sites and build up a profile of your interests. If you do not allow these cookies you may not be able to see or use the content sharing tools.

Advertising cookies may be used to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but work by uniquely identifying your browser and internet device. If you do not allow these cookies, you will still see ads, but they won’t be tailored to your interests.

Course type

Qualification, university name, full time phd degree pharmacy courses at cardiff university.

2 courses available

Customise your search

Select the start date, qualification, and how you want to study

Related subjects:

• PhD Pharmacy
• PhD Dentistry
• PhD Immunology
• PhD Medical Sciences
• PhD Medical Technology
• PhD Oncology
• PhD Ophthalmology
• PhD Optometry
• PhD Pathology
• PhD Pharmacology
• PhD Psychiatry
• PhD Surgery, Medicine and Dentistry

• Course title (A-Z)
• Course title (Z-A)
• Price: high - low
• Price: low - high

Pharmacy Practice and Clinical Pharmacy (MPhil, MD, PhD)

Cardiff university.

Pharmacy Practice and Clinical Pharmacy is a research area within which you can focus your studies as part of our suite of Pharmacy and Read more...

• 3 years Full time degree
• 5 years Part time degree

Pharmacy and Pharmaceutical Sciences (MPhil, MD, PhD)

We welcome applications from students interested in researching for a PhD within our diverse research portfolio. We focus on the discovery, Read more...

Course type:

• Full time PhD
• Part time PhD

Qualification:

Related subjects:.

Admission office: +7 969 2834820 [email protected]

MBBS in Russia | MBBS in Moscow | Study Pharmacy in Russia | Study Pharmacy in Moscow | Pharmacy Education in Russia | Education in Moscow | MBBS Admission in I.M. Sechenov First Moscow State Medical University | MBBS Fee in I.M. Sechenov First Moscow State Medical University | How to Get Direct Admission in MBBS in I.M. Sechenov First Moscow State Medical University | Study Pharmacy in I.M. Sechenov First Moscow State Medical University | About Pharmacy in I.M. Sechenov First Moscow State Medical University | Pharmacy Tuition Fee in I.M. Sechenov First Moscow State Medical University | Faculty of Pharmacy in I.M. Sechenov First Moscow State Medical University

Direction : Pharmacy Certificate, degree or qualification:  Pharmaceutical Chemist Level:  Specialist’s Degree Subject:  Pharmacy Code:  33.05.01 Language of instruction:  Russian, English

The education program is focused on training of pharmaceutical chemists able to carrying out self-dependent pharmaceutical practice. Training is practice-oriented and is aimed at formation of common cultural and professional competencies which let providing drug circulation in accordance with the requirements and regulations.

Program staffing: doctors and candidates of sciences, academicians of the Russian Academy of Science, leading specialists of healthcare and medical insurance system.

Features of implementation:

– laboratories, equipped with high-tech equipment,

– interactive study technologies, use of multimedia equipment and internet communication, practical training with the help of simulation technologies.

Potential and actual business partners: pharmaceutical organizations, bodies of surveillance and control in the sphere of pharmacy, healthcare management bodies of various levels, medical insurance companies.

Graduates of the program are in demand in organizations of surveillance and control in the sphere of pharmacy, public national and international health protection organizations, professional pharmaceutical associations. The program provides possibility to learn one or more additional vocational programs, to get simultaneously a second or continued higher education. Graduates of the program have the opportunity to easily design their professional career, in particular to study in Residency and for a Ph.D. degree.

Admission is open

• Admission process
• Admission requirements
• Application form
• Admission 2021-2022
• Tuition fee
• Apply online
• Visa requirements
• Our representatives
• Russian embassies
• Airport pickup

Admission 2021-2022 is open now. Join to thousands of happy students in First Moscow State Medical University

Admission Office

Admission office for international students.

Adfress: 119991, Moscow, Trubetskaya street, house 8, building 2, Russia

Phone: +7 (969) 283-48-20

Email: [email protected]

Season’s Greetings from Sechenov University

University News | Student life in Russia | Student life in Moscow | News and events in Russia | News and events in Moscow | Study in Russia | Study in Moscow | Education in Russia | Education in Moscow | Study abroad in Russia | International students life abroad | Study abroad in Russia…

Sechenov University Maintained its Position in the 5-100 Project

• Faculties and Departments
• University Leadership
• FMSMU Worldwide
• Clinics of FMSMU

Copyright © 2020-2023 First Moscow State Medical University. All Rights Reserved.

International Public Relations and Communication (MA)

• Duration: 1 year
• Mode: Full time

Find out more about studying here as a postgraduate at our next Open Day .

Why study this course

An internationally recognised, accredited course that equips you with the knowledge, understanding and practice-based skills to develop as a public relations and strategic communications specialist.

Professional accreditation

The course is accredited by the Chartered Institute of Public Relations, the largest professional body for public relations practitioners in Europe with global influence at all levels and sectors of the industry.

A global viewpoint

A learning community from a range of national and cultural backgrounds allowing you to gain a global perspective of PR practice.

Ranked for excellence

Study with one of the UK’s leading schools, ranked top 40 in the 2024 QS World University Rankings for Communication and Media Studies.

Centrally-located

Study in the heart of Cardiff’s vibrant media quarter in a purpose-built facility adjacent to the new BBC Cymru/Wales building.

Our MA International Public Relations and Communications programme is designed to equip you with the essential skills and techniques you'll need to succeed as a PR and communications professional across a diverse range of industries on a global scale. Our curriculum is tailored to meet the evolving demands of this thriving industry, catering to a wide spectrum of sectors and organizations.

You will gain a solid grounding in PR knowledge, skills and practice by a faculty comprised of academic staff and practitioners, all of whom bring their unique and diverse perspectives into their teaching. It is this blend of research and experience, spanning multiple sectors and countries, that helps make our programme distinctive.

You will gain a theoretical and practical understanding of public relations and also develop industry-relevant skills relating to the planning, strategy, delivery and evaluation of effective communications. You will also be able to explore a range of specialised areas, tailoring part of your learning experience with a choice of options to help align the programme with your career interests or aspirations.

Our assignments are crafted to facilitate the practical application of theory and to help you demonstrate a critical understanding of what is being taught. The dissertation component provides a unique opportunity for you to pursue a research area of your choice in the field of PR and communications. This major project fosters in-depth analysis and understanding within a specific practice area, supporting your intended specialism or professional interests.

Graduating from our CIPR-accredited program not only enhances your academic qualifications but also positions you within a network of forward-thinking and respected PR and communications professionals. This credential serves as a valuable addition to your CV, demonstrating your commitment to growth and excellence in this field.

Accreditations

• Chartered Institute of Public Relations (CIPR)

Where you'll study

School of Journalism, Media and Culture

We provide a scholarly environment to help you acquire both the knowledge and skills needed to enter your chosen area of the media.

• Facilities Chevron right
• Academic staff Chevron right
• Our location Chevron right
• Telephone +44(0)29 2087 4786
• Marker Central Square, Cardiff, CF10 1FS

Admissions criteria

In order to be considered for an offer for this programme you will need to meet all of the entry requirements. Your application will not be progressed if the information and evidence listed is not provided.

With your online application you will need to provide:

• A copy of your degree certificate and transcripts which show you have achieved a 2:2 honours degree in any subject, or an equivalent international degree. If your degree certificate or result is pending, please upload any interim transcripts or provisional certificates.
• A copy of your IELTS certificate with an overall score of 7.0 with 6.0 in all subskills, or evidence of an accepted equivalent. Please include the date of your expected test if this qualification is pending. If you have alternative acceptable evidence, such as an undergraduate degree studied in the UK, please supply this in place of an IELTS.
• A personal statement of no more than 300 words in total, which covers the following:
• your interest in and passion for this specific programme at Cardiff University (100-150 words)
• your aspirations and motivations for working in the public relations and communications sector (100-150 words).

If you do not have a degree, your application may be considered on the basis of your professional experience. Please provide additional evidence to support your application such as signed and dated employer references.

Application Deadline

We allocate places on a first-come, first-served basis, so we recommend you apply as early as possible. Applications normally close at the end of August but may close sooner if all places are filled.

Selection process

We will review your application, including your personal statement (to assess your suitability for and understanding of the programme), and if you meet all of the entry requirements, and places are still available, we will make you an offer.

Find out more about English language requirements .

Criminal convictions

You are not required to complete a DBS (Disclosure Barring Service) check or provide a Certificate of Good Conduct to study this course.

If you are currently subject to any licence condition or monitoring restriction that could affect your ability to successfully complete your studies, you will be required to disclose your criminal record. Conditions include, but are not limited to:

• access to computers or devices that can store images
• use of internet and communication tools/devices
• freedom of movement
• contact with people related to Cardiff University.

Course structure

This is a full-time course that is completed in two stages. The first stage is taught across two semesters (Autumn and Spring) from the end of September to the beginning of June.

The second stage of the programme is a dissertation project that you will complete during the Summer period. This is an opportunity for you to complete a programme-related research project of your choice, for example, to support your PR interests or career aspirations.

The modules shown are an example of the typical curriculum and will be reviewed prior to the 2025/26 academic year. The final modules will be published by September 2025.

During the autumn and spring semesters, you'll complete 4 essential modules relating to international public relations and communication. These will equip you with core knowledge and skills relating to public relations theory, practice, communications management, and research.

You'll choose 2 further optional modules that relate to significant areas of contemporary PR and communications practice. These are designed to allow you to tailor this part of the programme towards your career interests or aspirations. Module capacity is limited but you can select one module from each of the following groups:

Group 1: Domains of practice Corporate communication  Brand communication  Culture and communication

Group 2: Drivers of practice Data-driven communication  Behaviour-change communication  Purpose-led communication

The second stage of the programme is to complete a scholarly research project which is a required part of a master’s degree programme. It requires in-depth investigation and analysis of a specific PR and communications topic of your choice, for example, relevant to your professional interests or career goals

You'll need to complete original research by reviewing existing literature, gathering data, and presenting your findings in the dissertation. The dissertation allows you to demonstrate mastery of the topic, critical thinking, and research skills as well as fresh insights relevant to PR and communications.

The University is committed to providing a wide range of module options where possible, but please be aware that whilst every effort is made to offer choice this may be limited in certain circumstances. This is due to the fact that some modules have limited numbers of places available, which are allocated on a first-come, first-served basis, while others have minimum student numbers required before they will run, to ensure that an appropriate quality of education can be delivered; some modules require students to have already taken particular subjects, and others are core or required on the programme you are taking. Modules may also be limited due to timetable clashes, and although the University works to minimise disruption to choice, we advise you to seek advice from the relevant School on the module choices available.

Learning and assessment

How will i be taught.

You will be taught through lectures, online materials, seminars, and workshops to deliver both the practical and academic elements of the course. You will also hear from industry-leading professionals through the expert lecture series which is a regular part of this programme.

How will I be assessed?

The main method of assessment on this programme is written coursework such as an academic essay or professional-style report. Most of these assessments are completed individually and there are some group projects included to demonstrate your experience of team working and collaboration.

How will I be supported?

We offer a wealth of support for postgraduate students, including specialist support for international students via the Student Connect team based in the university’s Centre for Student Life. The School of Journalism, Media and Culture also has a dedicated Student Support team to help you with many practical aspects of your programme or direct you to other resources.

Academic support

During the programme, our experienced lecturers and tutors will be on hand to provide help with the academic content for each of your modules. Their help and support is available within the regular in-person seminars and you can also contact them by email during the teaching weeks if you have further questions.

In each module you will receive feedback on your work and for every assessment we provide written feedback as part of the marking process. Other feedback is less formal and takes place as your participate in the various seminars and activities held during the programme.

Academic resources

To support your study you will have access to a large library of resources and other materials. Your will be directed to many of these as the course progresses, but all essential programme and module materials are hosted online in a dedicated online portal which you can access 24/7 throughout the programme.

You will also be able to access Cardiff University libraries across campus, including the school’s library right at the heart of our building in Central Square. Online access is also provided to more than 1.5 million books, journals and other resources. Our library resources are particularly helpful when working on your research project and preparing your dissertation towards the end of the programme. This is a critical and substantial part of the degree, and we will make sure that you are offered the support of an academic supervisor as you develop your project.

Other support

You will also have a personal tutor during the programme and who can provide general academic advice. If you are experiencing difficulties, they will be there to listen and help to direct you to the appropriate source of support. In addition, more specialist support services are available via Student Connect and our Student Life teams.

Located in the purpose-built Centre for Student Life, these support services encompass: Advice and Money, Student Futures for careers support, Counselling services, Health and Wellbeing, the Student Disability Service including dyslexia support, Academic Study Skills and Student Mentoring. Our Student Connect services can also provide guidance in areas more specific to international students such as visas and immigration requirements.

What skills will I practise and develop?

The Learning Outcomes for this Programme describe what you will achieve by the end of your programme at Cardiff University and identify the knowledge and skills that you will develop . They will also help you to understand what is expected of you.

On successful completion of your Programme you will be able to:

Knowledge & Understanding:

• Demonstrate a critical understanding of the theoretical frameworks, concepts, and principles that underpin public relations and the role that it plays at local, national, and international levels of economic, political and social organisation. 
• Relate the diversity of approaches to public relations and communication to current domains or drivers of practice, evaluating their cultural, social and political implications.
• Express, in detail, evaluation approaches for assessing the effectiveness and impact of public relations campaigns or other strategic communication activities.
• Examine the global perspectives and intercultural dynamics that influence public relations practice, demonstrating an awareness of their impact on organisational reputation and the effectiveness of its communication.

Intellectual Skills:

• Critically assess and apply relevant knowledge to a range of complex situations drawing on techniques of research and enquiry sufficient to allow detailed investigation of public relations issues within their organisational, social, and cultural context.
• Synthesise complex information from multiple disciplines to develop coherent and persuasive communications strategies tailored to diverse stakeholders and contexts.
• Conduct research into public relations and communications management issues, showing a critical understanding of how to evaluate (the rigour and validity of) new or existing data and apply it to new situations or approaches to practice. 

Professional Practical Skills:

• Develop and plan public relations campaigns that align with organisational aims and objectives by integrating strategic thinking, audience analysis and the tactical planning of online and offline channels.
• Select and apply a range of professional communication and media practices in response to organisational issues or problems, demonstrating skills in both strategic thinking and pragmatic execution. 
• Research and engage with creative processes to create a range of public relations outputs, understanding how to interpret this material for the needs of differing audiences, stakeholders, platforms and communications objectives.
• Demonstrate responsibility and self-management in progressing their learning and professional development, reflecting on progress and responding to feedback with appropriate action.

Transferable/Key Skills:

• Work across a variety of individual, group and self-managed modes of study, demonstrating initiative, motivation, creativity and the capacity for critical self-reflection.
• Collaborate effectively by demonstrating teamwork and professionalism, respecting different contributions or perspectives, and able to resolve conflicts in a reasonable, negotiated manner. 
• Apply advanced problem-solving and decision-making skills, employing critical judgement and creativity to address complex issues and challenges within the communications profession.
• Analyse and synthesise data and information from a variety of sources, to evaluate its relevance and validity, and synthesise its application to real-world situations or professional contexts. 
• Demonstrate intellectual curiosity, independent critical thinking and an ability to express ideas effectively, communicating clearly both orally and in writing, using a variety of media.

Tuition fees for 2025 entry

Your tuition fees and how you pay them will depend on your fee status. Your fee status could be home, island or overseas.

Learn how we decide your fee status

Fees for home status

Fees for entry 2025/26 are not yet available.

Students from the EU, EEA and Switzerland

We are currently awaiting confirmation on tuition fees for the 2025/26 academic year.

Fees for island status

Learn more about the postgraduate fees for students from the Channel Islands or the Isle of Man .

Fees for overseas status

Additional costs, living costs.

We’re based in one of the UK’s most affordable cities. Find out more about living costs in Cardiff .

Master's Scholarships

An award open to UK students intending to study one of our taught master’s degrees.

Postgraduate loans

If you are starting your master’s degree in September 2024 or later, you may be able to apply for a postgraduate loan to support your study at Cardiff University.

Career prospects

Your academic qualification from this professionally accredited programme will prepare your for a wide range of PR and communications roles. The high-level skills you have developed during the programme such as effective communication, critical thinking, and industry knowledge are highly valued by employers. Our graduates of this programme are currently employed in many sectors around the world as PR executives, communication managers, media relations officers and many other specialist roles.

Open Day visits

Make an enquiry, international, discover more.

Search for your courses

Related searches: Journalism , Language and communication , Public relations

HESA Data: Copyright Higher Education Statistics Agency Limited 2021. The Higher Education Statistics Agency Limited cannot accept responsibility for any inferences or conclusions derived by third parties from its data. Data is from the latest Graduate Outcomes Survey 2019/20, published by HESA in June 2022.

Module information

Postgraduate

Be part of a thriving postgraduate community in a university known internationally for outstanding research and teaching.

Postgraduate prospectus 2024

Download a copy of our prospectus, school and subject brochures, and other guides.

Order or download

Get in touch if you have a question about studying with us.